NDC 0641-6053-01 - MEPERIDINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6053
- Requested NDC
- 0641-6053-01
- Package NDCs from labels
- 0641-6053-01, 0641-6053-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MEPERIDINE HYDROCHLORIDE - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6053-01 | MEPERIDINE HYDROCHLORIDE | 1 mL in 1 VIAL | INJECTION | 1 | 11 | |
| 0641-6053-25 | MEPERIDINE HYDROCHLORIDE | 25 in 1 CARTON | INJECTION | 25 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6053-01 | ML - Milliliter | 0641-6053 | 7bda1246-b4bf-48aa-9fab-c8b4ada68c19 | 1 | 2012-07-24 |
| 0641-6053-25 | ML - Milliliter | 0641-6053 | 5c2ed807-7080-4309-9e17-5be5cd94277d | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MEPERIDINE HYDROCHLORIDE | ACTIVE INGREDIENT | N8E7F7Q170 | MEPERIDINE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 | |
| MEPERIDINE | ACTIVE MOIETY | 9E338QE28F | MEPERIDINE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | MEPERIDINE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 | |
| SODIUM ACETATE | INACTIVE INGREDIENT | 4550K0SC9B | MEPERIDINE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | MEPERIDINE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Advanced Eye Relief Eye Wash | WATER SOLUTION | Bausch & Lomb Incorporated | 9caccce1-4530-441d-bf76-244edeb9dedc | 2025-02-17 | Warnings | 059QF0KO0R |
| Acetic Acid | ACETIC ACID | NuCare Pharmaceuticals,Inc. | f9b4d18b-25f3-604f-e053-6394a90a5531 | 2025-02-10 | Warnings, Adverse reactions | Q40Q9N063P |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products, Inc. | 2d90c8e8-f479-3535-e063-6394a90af122 | 2025-02-07 | Warnings | 059QF0KO0R |
| Bestmade Natural Products BM63 | CEANOTHUS, KALI MUR, KALI ARS, OOPHRINUM, SELENIUM, THALLIUM, WEISBADEN | Bestmade Natural Products | 2cea4552-3700-3da3-e063-6294a90a14b5 | 2025-01-30 | Warnings | 059QF0KO0R |
| Endopan HP | ACETICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, BRYONIA (ALBA), CHROMIUM, COLCHICUM AUTUMNALE, LACTICUM ACIDUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, SYZYGIUM JAMBOLANUM, THUJA OCCIDENTALIS, URANIUM NITRICUM | Energique, Inc. | 2bc69a24-c24c-4d12-92bb-7c073edf90dc | 2025-01-24 | Warnings | Q40Q9N063P |
| Medics Choice Soothing Eye Wash | PURIFIED WATER | KC Pharmaceuticals, Inc. | 10e49808-161e-f4ec-e063-6294a90a1775 | 2025-01-19 | Warnings | 059QF0KO0R |
| Sodium Acetate | SODIUM ACETATE | MILLA PHARMACEUTICALS INC. | 1ea04916-78e5-4651-e063-6394a90ac4be | 2025-01-16 | Warnings, Adverse reactions | 4550K0SC9B |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2b9456-8ca0-8253-e053-2a95a90a8f12 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2a34f9-ed95-9921-e053-2995a90a0d59 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2bc45d-e0c8-3af2-e053-2a95a90af0f1 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67169d-6b15-3406-e053-2995a90a60e4 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a673225-27be-040a-e053-2a95a90a0a98 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66b61d-82bd-2bbb-e053-2995a90a0b58 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a677063-09d2-8052-e053-2a95a90affae | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a678fac-289c-0f5c-e053-2995a90a0f43 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66da0b-ee7b-2b69-e053-2995a90ae951 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a667d80-d05c-2d18-e053-2995a90a2918 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66e2a9-a661-e847-e053-2a95a90aa304 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67a0bb-6943-2f5f-e053-2a95a90aac6e | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a6711a9-e0a4-9083-e053-2a95a90ad4a4 | 2025-01-09 | Q40Q9N063P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.